{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T16:35:05Z","timestamp":1774456505113,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Variants of <jats:italic>SORL1<\/jats:italic> have been associated with both late and early onset of Alzheimer\u2019s disease (AD). <jats:italic>SORL1<\/jats:italic> encodes the sorting-related receptor with A repeat (SORLA) protein, which belongs to the VPS10 receptor family. SORLA protects against AD pathogenesis through its sorting function, and reduced SORLA levels have been consistently observed in sporadic AD. Although the importance of SORLA in AD pathogenesis is well recognized, how it can be targeted for AD treatment remains to be established, owing to the inadequate understanding of its regulation by intracellular signaling.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We employed combined biochemical, cell biological, and pharmacological approaches to investigate how SORLA trafficking and stability are regulated. Additionally, we used an AD mouse model, postmortem tissue samples, and iPSC-derived neurons to examine the functional outcomes of this regulation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified a novel direct interaction between SORLA and \u03b2-arrestin2 (\u03b2ARR2), which impedes the interaction of SORLA with the retromer complex, thus reducing the retrograde trafficking of SORLA. \u03b2ARR2 promotes the interaction between SORLA and the ESCRT0 complex, leading to the lysosomal localization and degradation of SORLA. We also found that PKC\u03b9\/\u03bb induces SORLA phosphorylation and enhances its interaction with \u03b2ARR2, promoting SORLA degradation. Importantly, blocking PKC\u03b9\/\u03bb with auranofin disrupts the SORLA-\u03b2ARR2 interaction, elevates SORLA levels, decreases amyloidogenic processing of APP, and improves cognition in the <jats:italic>App<\/jats:italic>\n              <jats:sup>\n                <jats:italic>NL\u2212G\u2212F\/NL\u2212G\u2212F<\/jats:italic>\n              <\/jats:sup> AD mouse model. Furthermore, PKC\u03b9 is hyperactive in human AD brains, and auranofin reduces A\u03b2 production in AD iPSC-derived neurons through increasing SORLA levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study reveals the PKC\u03b9\/\u03bb-\u03b2ARR2 axis as a key molecular mechanism that disrupts SORLA retrograde trafficking and drives its degradation. Our findings represent the first evidence that SORLA levels can be pharmacologically manipulated through blocking PKC\u03b9\/\u03bb to reduce A\u03b2 production and alleviate AD-related phenotypes. Notably, repurposing auranofin, an FDA-approved drug for rheumatoid arthritis, may offer the potential for AD treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13024-025-00865-6","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T16:39:19Z","timestamp":1750696759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The PKC\u03b9-\u03b2-arrestin2 axis disrupts SORLA retrograde trafficking, driving its degradation and amyloid pathology in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Hasibur","family":"Rehman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalini","family":"Saggu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mae","family":"Aida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Trang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Dew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily T.","family":"Claeboe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Anthony J.","family":"Baucum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1079-5914","authenticated-orcid":false,"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"865_CR1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00401-016-1615-4","volume":"132","author":"OM Andersen","year":"2016","unstructured":"Andersen OM, Rudolph IM, Willnow TE. Risk factor SORL1: from genetic association to functional validation in Alzheimer\u2019s disease. Acta Neuropathol. 2016;132:653\u201365.","journal-title":"Acta Neuropathol"},{"key":"865_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet. 2007;39:168\u201377.","journal-title":"Nat Genet"},{"key":"865_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00401-019-01991-4","volume":"138","author":"D Campion","year":"2019","unstructured":"Campion D, Charbonnier C, Nicolas G. SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data. Acta Neuropathol. 2019;138:173\u201386.","journal-title":"Acta Neuropathol"},{"key":"865_CR4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/archneur.61.8.1200","volume":"61","author":"CR Scherzer","year":"2004","unstructured":"Scherzer CR, Offe K, Gearing M, Rees HD, Fang G, Heilman CJ, Schaller C, Bujo H, Levey AI, Lah JJ. Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch Neurol. 2004;61:1200\u20135.","journal-title":"Arch Neurol"},{"key":"865_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/mp.2012.15","volume":"17","author":"C Pottier","year":"2012","unstructured":"Pottier C, Hannequin D, Coutant S, Rovelet-Lecrux A, Wallon D, Rousseau S, Legallic S, Paquet C, Bombois S, Pariente J, et al. High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry. 2012;17:875\u20139.","journal-title":"Mol Psychiatry"},{"key":"865_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00401-016-1566-9","volume":"132","author":"J Verheijen","year":"2016","unstructured":"Verheijen J, Van den Bossche T, van der Zee J, Engelborghs S, Sanchez-Valle R, Llado A, Graff C, Thonberg H, Pastor P, Ortega-Cubero S, et al. A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer\u2019s disease. Acta Neuropathol. 2016;132:213\u201324.","journal-title":"Acta Neuropathol"},{"key":"865_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40478-017-0441-9","volume":"5","author":"H Thonberg","year":"2017","unstructured":"Thonberg H, Chiang HH, Lilius L, Forsell C, Lindstrom AK, Johansson C, Bjorkstrom J, Thordardottir S, Sleegers K, Van Broeckhoven C, Ronnback A, Graff C. Identification and description of three families with familial Alzheimer disease that segregate variants in the SORL1 gene. Acta Neuropathol Commun. 2017;5:43.","journal-title":"Acta Neuropathol Commun"},{"key":"865_CR8","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.1073\/pnas.0503689102","volume":"102","author":"OM Andersen","year":"2005","unstructured":"Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, von Arnim CA, Breiderhoff T, Jansen P, Wu X, et al. Neuronal sorting protein-related receptor sorLA\/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci U S A. 2005;102:13461\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"865_CR9","doi-asserted-by":"publisher","first-page":"223ra220","DOI":"10.1126\/scitranslmed.3007747","volume":"6","author":"S Caglayan","year":"2014","unstructured":"Caglayan S, Takagi-Niidome S, Liao F, Carlo AS, Schmidt V, Burgert T, Kitago Y, Fuchtbauer EM, Fuchtbauer A, Holtzman DM, Takagi J, Willnow TE. Lysosomal sorting of amyloid-beta by the SORLA receptor is impaired by a familial Alzheimer\u2019s disease mutation. Sci Transl Med. 2014;6:223ra220.","journal-title":"Sci Transl Med"},{"key":"865_CR10","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.1523\/JNEUROSCI.4582-08.2008","volume":"28","author":"SE Dodson","year":"2008","unstructured":"Dodson SE, Andersen OM, Karmali V, Fritz JJ, Cheng D, Peng J, Levey AI, Willnow TE, Lah JJ. Loss of LR11\/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer\u2019s disease. J Neurosci. 2008;28:12877\u201386.","journal-title":"J Neurosci"},{"key":"865_CR11","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.1128\/MCB.00815-07","volume":"27","author":"MS Nielsen","year":"2007","unstructured":"Nielsen MS, Gustafsen C, Madsen P, Nyengaard JR, Hermey G, Bakke O, Mari M, Schu P, Pohlmann R, Dennes A, Petersen CM. Sorting by the cytoplasmic domain of the amyloid precursor protein binding receptor SorLA. Mol Cell Biol. 2007;27:6842\u201351.","journal-title":"Mol Cell Biol"},{"key":"865_CR12","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1242\/jcs.009654","volume":"120","author":"MN Seaman","year":"2007","unstructured":"Seaman MN. Identification of a novel conserved sorting motif required for retromer-mediated endosome-to-TGN retrieval. J Cell Sci. 2007;120:2378\u201389.","journal-title":"J Cell Sci"},{"key":"865_CR13","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1523\/JNEUROSCI.2272-11.2012","volume":"32","author":"AW Fjorback","year":"2012","unstructured":"Fjorback AW, Seaman M, Gustafsen C, Mehmedbasic A, Gokool S, Wu C, Militz D, Schmidt V, Madsen P, Nyengaard JR, et al. Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processing. J Neurosci. 2012;32:1467\u201380.","journal-title":"J Neurosci"},{"key":"865_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0014-5793(01)03299-9","volume":"511","author":"L Jacobsen","year":"2002","unstructured":"Jacobsen L, Madsen P, Nielsen MS, Geraerts WP, Gliemann J, Smit AB, Petersen CM. The sorLA cytoplasmic domain interacts with GGA1 and -2 and defines minimum requirements for GGA binding. FEBS Lett. 2002;511:155\u20138.","journal-title":"FEBS Lett"},{"key":"865_CR15","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1091\/mbc.e12-01-0014","volume":"23","author":"JH Herskowitz","year":"2012","unstructured":"Herskowitz JH, Offe K, Deshpande A, Kahn RA, Levey AI, Lah JJ. GGA1-mediated endocytic traffic of LR11\/SorLA alters APP intracellular distribution and amyloid-beta production. Mol Biol Cell. 2012;23:2645\u201357.","journal-title":"Mol Biol Cell"},{"key":"865_CR16","doi-asserted-by":"publisher","first-page":"7996","DOI":"10.1523\/JNEUROSCI.0206-16.2016","volume":"36","author":"TY Huang","year":"2016","unstructured":"Huang TY, Zhao Y, Li X, Wang X, Tseng IC, Thompson R, Tu S, Willnow TE, Zhang YW, Xu H. SNX27 and SORLA Interact to Reduce Amyloidogenic Subcellular Distribution and Processing of Amyloid Precursor Protein. J Neurosci. 2016;36:7996\u20138011.","journal-title":"J Neurosci"},{"key":"865_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1523\/JNEUROSCI.3882-05.2006","volume":"26","author":"R Spoelgen","year":"2006","unstructured":"Spoelgen R, von Arnim CA, Thomas AV, Peltan ID, Koker M, Deng A, Irizarry MC, Andersen OM, Willnow TE, Hyman BT. Interaction of the cytosolic domains of sorLA\/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme. J Neurosci. 2006;26:418\u201328.","journal-title":"J Neurosci"},{"key":"865_CR18","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1523\/JNEUROSCI.4946-05.2006","volume":"26","author":"K Offe","year":"2006","unstructured":"Offe K, Dodson SE, Shoemaker JT, Fritz JJ, Gearing M, Levey AI, Lah JJ. The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J Neurosci. 2006;26:1596\u2013603.","journal-title":"J Neurosci"},{"key":"865_CR19","doi-asserted-by":"crossref","unstructured":"Knupp A, Mishra S, Martinez R, Braggin JE, Szabo M, Hailey DW, Small SA, Jayadev S, Young JE: Depletion of the AD risk gene SORL1 selectively impairs neuronal endosomal traffic independent of amyloidogenic APP processing. bioRxiv 2020.","DOI":"10.1101\/2020.01.06.896670"},{"key":"865_CR20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.biopsych.2010.05.030","volume":"68","author":"SD Ginsberg","year":"2010","unstructured":"Ginsberg SD, Alldred MJ, Counts SE, Cataldo AM, Neve RL, Jiang Y, Wuu J, Chao MV, Mufson EJ, Nixon RA, Che S. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer\u2019s disease progression. Biol Psychiat. 2010;68:885\u201393.","journal-title":"Biol Psychiat"},{"key":"865_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00401-014-1379-7","volume":"129","author":"A Peric","year":"2015","unstructured":"Peric A, Annaert W. Early etiology of Alzheimer\u2019s disease: tipping the balance toward autophagy or endosomal dysfunction? Acta Neuropathol. 2015;129:363\u201381.","journal-title":"Acta Neuropathol"},{"key":"865_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neurobiolaging.2004.09.018","volume":"26","author":"RA Nixon","year":"2005","unstructured":"Nixon RA. Endosome function and dysfunction in Alzheimer\u2019s disease and other neurodegenerative diseases. Neurobiol Aging. 2005;26:373\u201382.","journal-title":"Neurobiol Aging"},{"key":"865_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s40263-019-00643-1","volume":"33","author":"JRT van Weering","year":"2019","unstructured":"van Weering JRT, Scheper W. Endolysosome and Autolysosome Dysfunction in Alzheimer\u2019s Disease: Where Intracellular and Extracellular Meet. CNS Drugs. 2019;33:639\u201348.","journal-title":"CNS Drugs"},{"key":"865_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107719","volume":"31","author":"A Knupp","year":"2020","unstructured":"Knupp A, Mishra S, Martinez R, Braggin JE, Szabo M, Kinoshita C, Hailey DW, Small SA, Jayadev S, Young JE. Depletion of the AD Risk Gene SORL1 Selectively Impairs Neuronal Endosomal Traffic Independent of Amyloidogenic APP Processing. Cell Rep. 2020;31: 107719.","journal-title":"Cell Rep"},{"key":"865_CR25","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/01.jnen.0000228205.19915.20","volume":"65","author":"SE Dodson","year":"2006","unstructured":"Dodson SE, Gearing M, Lippa CF, Montine TJ, Levey AI, Lah JJ. LR11\/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J Neuropathol Exp Neurol. 2006;65:866\u201372.","journal-title":"J Neuropathol Exp Neurol"},{"key":"865_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.tips.2011.05.002","volume":"32","author":"SK Shenoy","year":"2011","unstructured":"Shenoy SK, Lefkowitz RJ. beta-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol Sci. 2011;32:521\u201333.","journal-title":"Trends Pharmacol Sci"},{"key":"865_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-0-12-394440-5.00002-4","volume":"118","author":"L Aubry","year":"2013","unstructured":"Aubry L, Klein G. True arrestins and arrestin-fold proteins: a structure-based appraisal. Prog Mol Biol Transl Sci. 2013;118:21\u201356.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"865_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-4939-9158-7_2","volume":"1957","author":"SA Laporte","year":"2019","unstructured":"Laporte SA, Scott MGH. beta-Arrestins: Multitask Scaffolds Orchestrating the Where and When in Cell Signalling. Methods Mol Biol. 2019;1957:9\u201355.","journal-title":"Methods Mol Biol"},{"key":"865_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nm.3023","volume":"19","author":"A Thathiah","year":"2013","unstructured":"Thathiah A, Horre K, Snellinx A, Vandewyer E, Huang Y, Ciesielska M, De Kloe G, Munck S, De Strooper B. beta-arrestin 2 regulates Abeta generation and gamma-secretase activity in Alzheimer\u2019s disease. Nat Med. 2013;19:43\u20139.","journal-title":"Nat Med"},{"key":"865_CR30","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/1567205011666140317095014","volume":"11","author":"T Jiang","year":"2014","unstructured":"Jiang T, Yu JT, Wang YL, Wang HF, Zhang W, Hu N, Tan L, Sun L, Tan MS, Zhu XC, Tan L. The genetic variation of ARRB2 is associated with late-onset Alzheimer\u2019s disease in Han Chinese. Curr Alzheimer Res. 2014;11:408\u201312.","journal-title":"Curr Alzheimer Res"},{"key":"865_CR31","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1073\/pnas.1917194117","volume":"117","author":"JA Woo","year":"2020","unstructured":"Woo JA, Liu T, Fang CC, Castano MA, Kee T, Yrigoin K, Yan Y, Cazzaro S, Matlack J, Wang X, et al. beta-Arrestin2 oligomers impair the clearance of pathological tau and increase tau aggregates. Proc Natl Acad Sci U S A. 2020;117:5006\u201315.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"865_CR32","doi-asserted-by":"publisher","first-page":"50589","DOI":"10.1074\/jbc.M208503200","volume":"277","author":"Q Wang","year":"2002","unstructured":"Wang Q, Limbird LE. Regulated Interactions of the alpha 2A Adrenergic Receptor with Spinophilin, 14-3-3zeta, and Arrestin 3. J Biol Chem. 2002;277:50589\u201396.","journal-title":"J Biol Chem"},{"key":"865_CR33","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1128\/MCB.22.21.7633-7644.2002","volume":"22","author":"K Jiao","year":"2002","unstructured":"Jiao K, Zhou Y, Hogan BL. Identification of mZnf8, a mouse Kruppel-like transcriptional repressor, as a novel nuclear interaction partner of Smad1. Mol Cell Biol. 2002;22:7633\u201344.","journal-title":"Mol Cell Biol"},{"key":"865_CR34","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1242\/jcs.016246","volume":"121","author":"FA Wald","year":"2008","unstructured":"Wald FA, Oriolo AS, Mashukova A, Fregien NL, Langshaw AH, Salas PJ. Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells. J Cell Sci. 2008;121:644\u201354.","journal-title":"J Cell Sci"},{"key":"865_CR35","doi-asserted-by":"publisher","first-page":"34709","DOI":"10.1074\/jbc.M302016200","volume":"278","author":"JW Soh","year":"2003","unstructured":"Soh JW, Weinstein IB. Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J Biol Chem. 2003;278:34709\u201316.","journal-title":"J Biol Chem"},{"key":"865_CR36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, Iwata N, Saido TC. Single App knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci. 2014;17:661\u20133.","journal-title":"Nat Neurosci"},{"key":"865_CR37","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","volume":"286","author":"LM Bohn","year":"1999","unstructured":"Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science. 1999;286:2495\u20138.","journal-title":"Science"},{"key":"865_CR38","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1111\/bph.15193","volume":"177","author":"N Perciedu Sert","year":"2020","unstructured":"Perciedu Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Br J Pharmacol. 2020;177:3617\u201324.","journal-title":"Br J Pharmacol"},{"key":"865_CR39","doi-asserted-by":"publisher","first-page":"eadn8709","DOI":"10.1126\/sciadv.adn8709","volume":"10","author":"C Zhang","year":"2024","unstructured":"Zhang C, Aida M, Saggu S, Yu H, Zhou L, Rehman H, Jiao K, Liu R, Wang L, Wang Q. Androgen deprivation therapy exacerbates Alzheimer\u2019s-associated cognitive decline via increased brain immune cell infiltration. Sci Adv. 2024;10:eadn8709.","journal-title":"Sci Adv"},{"key":"865_CR40","doi-asserted-by":"publisher","first-page":"eaay6931","DOI":"10.1126\/scitranslmed.aay6931","volume":"12","author":"F Zhang","year":"2020","unstructured":"Zhang F, Gannon M, Chen Y, Yan S, Zhang S, Feng W, Tao J, Sha B, Liu Z, Saito T, et al. Beta-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3beta\/tau cascade. Sci Transl Med. 2020;12:eaay6931.","journal-title":"Sci Transl Med"},{"key":"865_CR41","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","volume":"185","author":"TE Tracy","year":"2022","unstructured":"Tracy TE, Madero-P\u00e9rez J, Swaney DL, Chang TS, Moritz M, Konrad C, Ward ME, Stevenson E, H\u00fcttenhain R, Kauwe G, et al. Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell. 2022;185:712-728.e714.","journal-title":"Cell"},{"key":"865_CR42","first-page":"16837","volume":"277","author":"YM Kim","year":"2002","unstructured":"Kim YM, Barak LS, Caron MG, Benovic JL. Regulation of arrestin-3 phosphorylation by casein kinase II. JBiolChem. 2002;277:16837\u201346.","journal-title":"JBiolChem"},{"key":"865_CR43","doi-asserted-by":"publisher","first-page":"17296","DOI":"10.1073\/pnas.1409513111","volume":"111","author":"Y Chen","year":"2014","unstructured":"Chen Y, Peng Y, Che P, Gannon M, Liu Y, Li L, Bu G, van Groen T, Jiao K, Wang Q. alpha(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction. Proc Natl Acad Sci U S A. 2014;111:17296\u2013301.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"865_CR44","doi-asserted-by":"publisher","first-page":"36063","DOI":"10.1074\/jbc.M111.261578","volume":"286","author":"C Cottingham","year":"2011","unstructured":"Cottingham C, Chen Y, Jiao K, Wang Q. The antidepressant desipramine is an arrestin-biased ligand at the \u03b12A-adrenergic receptor driving receptor down-regulation in vitro and in vivo. J Biol Chem. 2011;286:36063\u201375.","journal-title":"J Biol Chem"},{"key":"865_CR45","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nmeth1113","volume":"4","author":"L Kall","year":"2007","unstructured":"Kall L, Canterbury JD, Weston J, Noble WS, MacCoss MJ. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods. 2007;4:923\u20135.","journal-title":"Nat Methods"},{"key":"865_CR46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41467-017-02533-w","volume":"9","author":"AM Miranda","year":"2018","unstructured":"Miranda AM, Lasiecka ZM, Xu Y, Neufeld J, Shahriar S, Simoes S, Chan RB, Oliveira TG, Small SA, Di Paolo G. Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures. Nat Commun. 2018;9:291.","journal-title":"Nat Commun"},{"key":"865_CR47","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41380-022-01851-w","volume":"28","author":"S Saggu","year":"2023","unstructured":"Saggu S, Chen Y, Cottingham C, Rehman H, Wang H, Zhang S, Augelli-Szafran C, Lu S, Lambert N, Jiao K, Lu XY, Wang Q. Activation of a novel \u03b1(2A)AR-spinophilin-cofilin axis determines the effect of \u03b1(2) adrenergic drugs on fear memory reconsolidation. Mol Psychiatry. 2023;28:588\u2013600.","journal-title":"Mol Psychiatry"},{"key":"865_CR48","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nsmb1103","volume":"13","author":"H Shi","year":"2006","unstructured":"Shi H, Rojas R, Bonifacino JS, Hurley JH. The retromer subunit Vps26 has an arrestin fold and binds Vps35 through its C-terminal domain. Nat Struct Mol Biol. 2006;13:540\u20138.","journal-title":"Nat Struct Mol Biol"},{"key":"865_CR49","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1016\/j.cub.2012.01.028","volume":"22","author":"O Schmidt","year":"2012","unstructured":"Schmidt O, Teis D. The ESCRT machinery. Curr Biol. 2012;22:R116-120.","journal-title":"Curr Biol"},{"key":"865_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcdb.2017.08.020","volume":"74","author":"EB Frankel","year":"2018","unstructured":"Frankel EB, Audhya A. ESCRT-dependent cargo sorting at multivesicular endosomes. Semin Cell Dev Biol. 2018;74:4\u201310.","journal-title":"Semin Cell Dev Biol"},{"key":"865_CR51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1750-1326-5-62","volume":"5","author":"RF Lane","year":"2010","unstructured":"Lane RF, Gatson JW, Small SA, Ehrlich ME, Gandy S. Protein kinase C and rho activated coiled coil protein kinase 2 (ROCK2) modulate Alzheimer\u2019s APP metabolism and phosphorylation of the Vps10-domain protein, SorL1. Mol Neurodegener. 2010;5:62.","journal-title":"Mol Neurodegener"},{"key":"865_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tips.2003.12.008","volume":"25","author":"VV Gurevich","year":"2004","unstructured":"Gurevich VV, Gurevich EV. The molecular acrobatics of arrestin activation. Trends Pharmacol Sci. 2004;25:105\u201311.","journal-title":"Trends Pharmacol Sci"},{"key":"865_CR53","doi-asserted-by":"publisher","first-page":"19025","DOI":"10.1074\/jbc.274.27.19025","volume":"274","author":"YP Lim","year":"1999","unstructured":"Lim YP, Low BC, Lim J, Wong ES, Guy GR. Association of atypical protein kinase C isotypes with the docker protein FRS2 in fibroblast growth factor signaling. J Biol Chem. 1999;274:19025\u201334.","journal-title":"J Biol Chem"},{"key":"865_CR54","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1073\/pnas.90.18.8342","volume":"90","author":"TC Sacktor","year":"1993","unstructured":"Sacktor TC, Osten P, Valsamis H, Jiang X, Naik MU, Sublette E. Persistent activation of the zeta isoform of protein kinase C in the maintenance of long-term potentiation. Proc Natl Acad Sci U S A. 1993;90:8342\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"865_CR55","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.lfs.2013.04.005","volume":"92","author":"JM Madeira","year":"2013","unstructured":"Madeira JM, Renschler CJ, Mueller B, Hashioka S, Gibson DL, Klegeris A. Novel protective properties of auranofin: inhibition of human astrocyte cytotoxic secretions and direct neuroprotection. Life Sci. 2013;92:1072\u201380.","journal-title":"Life Sci"},{"key":"865_CR56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2212180120","volume":"120","author":"AMG Jensen","year":"2023","unstructured":"Jensen AMG, Kitago Y, Fazeli E, Vaegter CB, Small SA, Petsko GA, Andersen OM. Dimerization of the Alzheimer\u2019s disease pathogenic receptor SORLA regulates its association with retromer. Proc Natl Acad Sci U S A. 2023;120: e2212180120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"865_CR57","doi-asserted-by":"publisher","first-page":"18061","DOI":"10.1073\/pnas.0705550104","volume":"104","author":"C Boularan","year":"2007","unstructured":"Boularan C, Scott MG, Bourougaa K, Bellal M, Esteve E, Thuret A, Benmerah A, Tramier M, Coppey-Moisan M, Labbe-Jullie C, Fahraeus R, Marullo S. beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53. Proc Natl Acad Sci U S A. 2007;104:18061\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"865_CR58","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-3-642-41199-1_11","volume":"219","author":"Q Chen","year":"2014","unstructured":"Chen Q, Zhuo Y, Kim M, Hanson SM, Francis DJ, Vishnivetskiy SA, Altenbach C, Klug CS, Hubbell WL, Gurevich VV. Self-association of arrestin family members. Handb Exp Pharmacol. 2014;219:205\u201323.","journal-title":"Handb Exp Pharmacol"},{"key":"865_CR59","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.1074\/jbc.M110.167239","volume":"286","author":"JH Herskowitz","year":"2011","unstructured":"Herskowitz JH, Seyfried NT, Gearing M, Kahn RA, Peng J, Levey AI, Lah JJ. Rho kinase II phosphorylation of the lipoprotein receptor LR11\/SORLA alters amyloid-beta production. J Biol Chem. 2011;286:6117\u201327.","journal-title":"J Biol Chem"},{"key":"865_CR60","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/01.jnen.0000218441.00040.82","volume":"65","author":"CY Shao","year":"2006","unstructured":"Shao CY, Crary JF, Rao C, Sacktor TC, Mirra SS. Atypical protein kinase C in neurodegenerative disease II: PKCiota\/lambda in tauopathies and alpha-synucleinopathies. J Neuropathol Exp Neurol. 2006;65:327\u201335.","journal-title":"J Neuropathol Exp Neurol"},{"key":"865_CR61","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neurobiolaging.2017.09.001","volume":"61","author":"MP Sajan","year":"2018","unstructured":"Sajan MP, Hansen BC, Higgs MG, Kahn CR, Braun U, Leitges M, Park CR, Diamond DM, Farese RV. Atypical PKC, PKClambda\/iota, activates beta-secretase and increases Abeta(1\u201340\/42) and phospho-tau in mouse brain and isolated neuronal cells, and may link hyperinsulinemia and other aPKC activators to development of pathological and memory abnormalities in Alzheimer\u2019s disease. Neurobiol Aging. 2018;61:225\u201337.","journal-title":"Neurobiol Aging"},{"key":"865_CR62","doi-asserted-by":"publisher","first-page":"28450","DOI":"10.1074\/jbc.M606054200","volume":"281","author":"E Erdogan","year":"2006","unstructured":"Erdogan E, Lamark T, Stallings-Mann M, Lee J, Pellecchia M, Thompson EA, Johansen T, Fields AP. Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota. J Biol Chem. 2006;281:28450\u20139.","journal-title":"J Biol Chem"},{"key":"865_CR63","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10787-012-0149-1","volume":"20","author":"JM Madeira","year":"2012","unstructured":"Madeira JM, Gibson DL, Kean WF, Klegeris A. The biological activity of auranofin: implications for novel treatment of diseases. Inflammopharmacology. 2012;20:297\u2013306.","journal-title":"Inflammopharmacology"},{"key":"865_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.147022","volume":"1746","author":"J Upite","year":"2020","unstructured":"Upite J, Kadish I, van Groen T, Jansone B. Subchronic administration of auranofin reduced amyloid-beta plaque pathology in a transgenic APP(NL-G-F\/NL-G-F) mouse model. Brain Res. 2020;1746: 147022.","journal-title":"Brain Res"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00865-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00865-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00865-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T18:03:12Z","timestamp":1750701792000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00865-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["865"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00865-6","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mice were housed in the AAALAC-accredited Animal Resources Program facility at the Medical College of Georgia at Augusta University. This was done in accordance with the Animal Welfare Act, and all studies adhered to procedures approved by the Augusta University Institutional Animal Care and Use Committee (protocol number #2021\u20131061) and the UAB Institutional Animal Care and Use Committee (IACUC-22176), as well as IRB protocols #N140909007.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Q.W. serves on the Board of Scientific Advisory for Terran Biosciences, Inc. Q.W. and K.J. are co-founders of BioQure, LLC. Other authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}